These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 621670

  • 1. The effect of L-dopa on peripheral sympathetic nerve function: role of presynaptic dopamine receptors.
    Lokhandwala MF, Buckley JP.
    J Pharmacol Exp Ther; 1978 Feb; 204(2):362-71. PubMed ID: 621670
    [No Abstract] [Full Text] [Related]

  • 2. Mediation of enhanced reflex vagal bradycardia by L-dopa via central dopamine formation in dogs.
    Antonaccio MJ, Kerwin L.
    Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):56-68. PubMed ID: 869641
    [Abstract] [Full Text] [Related]

  • 3. Proceedings: The mechanism of the effect of dopamine-beta-hydroxylase inhibitor FLA-63 on the L-DOPA reversal of reserpine akinesia.
    Dolphin A, Jenner P, Marsden CD.
    Br J Pharmacol; 1975 Jun; 54(2):246P-247P. PubMed ID: 1148534
    [No Abstract] [Full Text] [Related]

  • 4. The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
    Ziegler MG, Kennedy B, Holland OB, Murphy D, Lake CR.
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):175-9. PubMed ID: 3158615
    [Abstract] [Full Text] [Related]

  • 5. Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
    Dadkar VN, Dahanukar SA, Sheth UK.
    Indian J Med Res; 1979 Sep; 70():492-4. PubMed ID: 535961
    [No Abstract] [Full Text] [Related]

  • 6. Centrally mediated increased reflex vagal bradycardia after L-dopa in monoamine oxidase-inhibited anesthetized dogs.
    Antonaccio MJ, Kerwin L.
    J Pharmacol Exp Ther; 1976 Feb; 196(2):380-8. PubMed ID: 1255483
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of L-DOPA on blood pressure and sympathetic nerve activity after decarboxylase inhibition in cats.
    Watanabe AM, Judy WV, Cardon PV.
    J Pharmacol Exp Ther; 1974 Jan; 188(1):107-13. PubMed ID: 4809262
    [No Abstract] [Full Text] [Related]

  • 9. Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs.
    Blair ML, Reid IA, Ganong WF.
    J Pharmacol Exp Ther; 1977 Jul; 202(1):209-15. PubMed ID: 874815
    [Abstract] [Full Text] [Related]

  • 10. Effect of L-dopa on human muscle sympathetic nerve activity.
    Takeuchi S, Sugiyama Y, Mano T, Iwase S, Matsukawa T.
    Environ Med; 1993 Jul; 37(1):99-102. PubMed ID: 12269353
    [Abstract] [Full Text] [Related]

  • 11. Presynaptic dopamine receptors as mediators of dopamine-induced inhibition of neurogenic vasoconstriction.
    Lokhandwala MF, Buckley JP.
    Eur J Pharmacol; 1977 Oct 01; 45(3):305-9. PubMed ID: 923639
    [Abstract] [Full Text] [Related]

  • 12. Age-dependent depressor effect of L-dopa in dogs with inhibition of extracerebral dopa decarboxylase.
    Wilke WL.
    Pediatr Res; 1983 Nov 01; 17(11):924-5. PubMed ID: 6359046
    [Abstract] [Full Text] [Related]

  • 13. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM, Parks LC, Kopin IJ.
    J Clin Invest; 1971 Jun 01; 50(6):1322-8. PubMed ID: 5578236
    [Abstract] [Full Text] [Related]

  • 14. The beta 2 receptor plays a role in the hypotensive effect of L-dopa.
    Quevedo M, Prieto JC, Pérez-Olea J.
    Acta Physiol Pharmacol Ther Latinoam; 1995 Jun 01; 45(1):19-25. PubMed ID: 8580515
    [Abstract] [Full Text] [Related]

  • 15. Reversal of sympathetic nerve blockade: a comparison of dopa, dopamine, and norepinephrine with their alpha-methylated analogues.
    Conradi EC, Gaffney TE, Fink DA, Vangrow JS.
    J Pharmacol Exp Ther; 1965 Oct 01; 150(1):26-33. PubMed ID: 5853699
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The irritant properties of dopamine-beta-hydroxylase inhibitors in relation to their effects on L-dopa-induced locomotor activity.
    Dolphin A, Elliott PN, Jenner P.
    J Pharm Pharmacol; 1976 Oct 01; 28(10):782-5. PubMed ID: 10378
    [No Abstract] [Full Text] [Related]

  • 18. The role of sympathetic nervous system in the action of dopamine and dobutamine on the function of circulatory system.
    Krawczak J, Beutler A, Kozłowska T, Olejnik A.
    Pol J Pharmacol Pharm; 1989 Oct 01; 41(6):639-48. PubMed ID: 2485908
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the effects of bromocriptine on blood pressure and sympathetic nerve function.
    Lokhandwala MF.
    Eur J Pharmacol; 1979 Jun 15; 56(3):253-6. PubMed ID: 477721
    [Abstract] [Full Text] [Related]

  • 20. [Action of a peripheral inhibitor of dopa-decarboxylase on the inhibition by L-DOPA of the hypothalamo-hypophyseo-adrenocortical system in man].
    Balestreri R, Bertolini S, Elicio N, Costa S.
    Boll Soc Ital Biol Sper; 1974 Jul 30; 50(12):832-7. PubMed ID: 4447697
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.